2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults

BACKGROUND: Routine use of 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for infants since early 2010 and for adults ≥65 years since 2014 when KPNC began routine use of PCV13 in adults. PCV13 vaccine effectiveness (VE) against vaccine-type invasive pneumococcal disease (IPD)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Lewis, Ned, Hsiao, Amber, Hansen, John, Yee, Arnold, Chao, Charlie, Suaya, Jose A, Alexander-Parrish, Ronika, Isturiz, Raul E, McLaughlin, John M, Gessner, Bradford D, Klein, Nicola
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811316/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.2388
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares